Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/28150
Title: Comparison of conventional external radiotherapy and stereotactic radiotherapy in the treatment of pituitary adenoma
Authors: Putipun Puataweepong
Mantana Dhanachai
Somjai Dangprasert
Jiraporn Laothamatas
Veerasak Theerapancharoen
Pornpan Yongvithisatid
Mahidol University
Keywords: Medicine
Issue Date: 1-Mar-2009
Citation: Journal of the Medical Association of Thailand. Vol.92, No.3 (2009), 382-389
Abstract: Objective: To compare the results of pituitary adenoma treated with conventional external beam radiotherapy (EBRT) versus stereotactic radiosurgery and stereotactic radiotherapy (SRS/SRT). Method and Material: Data of patients with pituitary adenoma treated at Radiotherapy and Oncology unit, Ramathibodi Hospital between 1990 from 2003 were retrospectively collected and analyzed. Twenty-two patients were treated with EBRT and 51 patients were treated with SRS/SRT. Results: The 5-year overall survival and local control rates were not different between the EBRT and SRS/SRT group (91% vs 100%, p = 0.10; 95% vs 96%, p = 0.33). The 5-year freedom from newly initiated hormonal replacement was 50% in EBRT and 75% in SRS/SRT group (p = 0.38). Conclusion: At a similar outcome but with lower expense of resources, EBRT should be considered an acceptable radiation technique for patients with pituitary adenoma, especially in developing countries such as Thailand. Puataweepong P, Radiotherapy and Oncology Unit, Department of Radiology, Ramathibodi Hospital, Mahidol University, Rama VI Rd, Phyathai, Rajtawee, 10400, Bangkok rapptw@mahidol.ac.th.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=63449117150&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/28150
ISSN: 01252208
01252208
Appears in Collections:Scopus 2006-2010

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.